Epitalon (Epithalon; AEDG): Evidence Before Hype
Epitalon is a synthetic tetrapeptide composed of Ala-Glu-Asp-Gly (AEDG) that has attracted considerable attention in longevity, telomere, circadian, and neuroendocrine research.
The Founder’s Institute of Medicine & Education Epitalon Peptide Intelligence Monograph examines the science behind these claims while making a critical distinction frequently lost in popular discussions: synthetic Epitalon is not the same substance as Epithalamin, the pineal polypeptide preparation used in several frequently cited human aging and survival studies.
Inside the monograph:
• Epitalon/AEDG molecular identity and pineal origins
• The critical distinction between Epitalon and Epithalamin
• Telomerase and telomere research
• Cellular aging and senescence-related evidence
• Melatonin, circadian rhythm, and neuroendocrine research
• Sleep and insomnia claims
• Neuroprotective and cognitive research
• Longevity and lifespan claims examined critically
• Human evidence and its substantial limitations
• Safety, tolerability, and oncologic uncertainty
• Product quality and administration considerations
• July 2026 FDA regulatory review
• Claim-by-claim FIPES evidence assessment
• Fully referenced scientific literature
Institute Bottom Line: Human longevity has not been established for synthetic Epitalon (AEDG). Frequently cited human survival findings involve Epithalamin, a pineal polypeptide preparation related to—but not interchangeable with—synthetic Epitalon. Mechanistic findings involving telomerase, telomeres, melatonin, and aging biology are scientifically intriguing, but they do not establish that Epitalon extends human lifespan or healthspan.
Version 1.0 | Evidence cutoff: August 25, 2026
Educational scientific evidence review. Not medical advice, a treatment protocol, prescription, or promotional claim.
This publication is provided solely for educational and informational purposes. It does not constitute medical advice, diagnosis, prescribing guidance, or a recommendation for individual treatment. It is not intended to replace evaluation, consultation, or treatment by a qualified healthcare professional. Treatment decisions must be based on the individual patient's circumstances and made in consultation with an appropriately licesnsed healthcare professional.